Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

33 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Intra-individual qualitative and quantitative comparison of [68Ga]Ga-DOTATATE PET/CT and PET/MRI.
Lens G, Ahmadi Bidakhvidi N, Vandecaveye V, Grauwels S, Laenen A, Deckers W, Peeters R, Dresen RC, Dekervel J, Verslype C, Nackaerts K, Clement PM, Van Cutsem E, Koole M, Goffin K, Van Laere K, Deroose CM. Lens G, et al. Among authors: dresen rc. Ther Adv Med Oncol. 2023 Oct 24;15:17588359231189133. doi: 10.1177/17588359231189133. eCollection 2023. Ther Adv Med Oncol. 2023. PMID: 37885461 Free PMC article.
Early Whole-Body Diffusion-weighted MRI Helps Predict Long-term Outcome Following Peptide Receptor Radionuclide Therapy for Metastatic Neuroendocrine Tumors.
Vandecaveye V, Dresen RC, Pauwels E, Van Binnebeek S, Vanslembrouck R, Baete K, Mottaghy FM, Clement PM, Nackaerts K, Van Cutsem E, Verslype C, De Keyzer F, Deroose CM. Vandecaveye V, et al. Among authors: dresen rc. Radiol Imaging Cancer. 2022 May;4(3):e210095. doi: 10.1148/rycan.210095. Radiol Imaging Cancer. 2022. PMID: 35621524 Free PMC article. Clinical Trial.
Transarterial Radioembolization Following Chemoembolization for Unresectable Hepatocellular Carcinoma: Response Based on Apparent Diffusion Coefficient Change is an Independent Predictor for Survival.
Klompenhouwer EG, Dresen RC, Verslype C, Laenen A, Bonne L, Vandecaveye V, Maleux G. Klompenhouwer EG, et al. Among authors: dresen rc. Cardiovasc Intervent Radiol. 2018 Nov;41(11):1716-1726. doi: 10.1007/s00270-018-1991-3. Epub 2018 Jun 5. Cardiovasc Intervent Radiol. 2018. PMID: 29872894
Nonoperative versus operative approach according to the response to neoadjuvant chemoradiotherapy for rectal cancer: A prospective cohort study.
Bulens PP, Smets L, Debucquoy A, Joye I, D'Hoore A, Wolthuis A, Debrun L, Dekervel J, Van Cutsem E, Dresen R, Vandecaveye V, Deroose CM, Sagaert X, Haustermans K. Bulens PP, et al. Clin Transl Radiat Oncol. 2022 Jul 26;36:113-120. doi: 10.1016/j.ctro.2022.07.009. eCollection 2022 Sep. Clin Transl Radiat Oncol. 2022. PMID: 35993092 Free PMC article.
Novel imaging techniques in gynaecological cancer.
Vandecaveye V, Dresen R, De Keyzer F. Vandecaveye V, et al. Curr Opin Oncol. 2017 Sep;29(5):335-342. doi: 10.1097/CCO.0000000000000385. Curr Opin Oncol. 2017. PMID: 28594645 Review.
Safety and Efficacy of Transarterial Radioembolisation in Patients with Intermediate or Advanced Stage Hepatocellular Carcinoma Refractory to Chemoembolisation.
Klompenhouwer EG, Dresen RC, Verslype C, Laenen A, De Hertogh G, Deroose CM, Bonne L, Vandevaveye V, Maleux G. Klompenhouwer EG, et al. Among authors: dresen rc. Cardiovasc Intervent Radiol. 2017 Dec;40(12):1882-1890. doi: 10.1007/s00270-017-1739-5. Epub 2017 Jul 6. Cardiovasc Intervent Radiol. 2017. PMID: 28685382
Imaging modalities in pregnant cancer patients.
Vandecaveye V, Amant F, Lecouvet F, Van Calsteren K, Dresen RC. Vandecaveye V, et al. Among authors: dresen rc. Int J Gynecol Cancer. 2021 Mar;31(3):423-431. doi: 10.1136/ijgc-2020-001779. Int J Gynecol Cancer. 2021. PMID: 33649009 Free PMC article. Review.
33 results